# Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial

Study · id `cardio:ct-nct01657461` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01657461](<https://clinicaltrials.gov/study/NCT01657461>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01657461

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 196 participants.

## Technical summary

Registry record NCT01657461. Randomized; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2015-01 (actual). Results posted on 2017-05-18.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 196 participants (enrolled count; ClinicalTrials.gov record NCT01657461, source copy `cardio:ctgov-nct01657461-2017-05-18`, retrieved 2026-10-26)
- Start date: 2012-12 (registry gives no type) (ClinicalTrials.gov record NCT01657461, source copy `cardio:ctgov-nct01657461-2017-05-18`, retrieved 2026-10-26)
- Primary completion: 2015-01 (actual) (ClinicalTrials.gov record NCT01657461, source copy `cardio:ctgov-nct01657461-2017-05-18`, retrieved 2026-10-26)
- Completion: 2015-01 (actual) (ClinicalTrials.gov record NCT01657461, source copy `cardio:ctgov-nct01657461-2017-05-18`, retrieved 2026-10-26)
- Results first posted: 2017-05-18 (ClinicalTrials.gov record NCT01657461, source copy `cardio:ctgov-nct01657461-2017-05-18`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01657461, source copy `cardio:ctgov-nct01657461-2017-05-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01657461-2017-05-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial
- Acronym: SWIFT PRIME
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Intravenous (IV) recombinant human tissue plasminogen activator (rtPA)
- Intervention (Device): Solitaire revascularization device
- Lead sponsor: Medtronic Neurovascular Clinical Affairs
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Medtronic Neurovascular Clinical Affairs (`cardio:org-medtronic-neurovascular-clinical-affairs`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke (`cardio:pubmed-25882376`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Relationships Between Imaging Assessments and Outcomes in Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (`cardio:pubmed-26316344`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke) (`cardio:pubmed-28028150`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Predictive Value of RAPID Assessed Perfusion Thresholds on Final Infarct Volume in SWIFT PRIME (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment) (`cardio:pubmed-28283606`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy of Stent-Retriever Thrombectomy in Magnetic Resonance Imaging Versus Computed Tomographic Perfusion-Selected Patients in SWIFT PRIME Trial (Solitaire FR With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke) (`cardio:pubmed-28465460`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Relative cerebral blood volume is associated with collateral status and infarct growth in stroke patients in SWIFT PRIME (`cardio:pubmed-29135347`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0036b2d9265f6f0ac080b4e41c2ced2939a7bca43f1054e12c0d10a9c719e6fd
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
